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Abstract
The enzyme that catalyzes the oxidation of fatty aldehyde derived from ether glycerolipid catabolism has not been
identified. To determine whether microsomal fatty aldehyde dehydrogenase (FALDH) is responsible, we investigated the
metabolism of 1-O-[9,10-3H-octadecyl]-glycerol ([3H]OG) in FALDH-deficient cultured cells from patients with Sjo«gren^
Larsson syndrome (SLS) and in mutant Chinese hamster ovary (CHO) cells. Intact fibroblasts from SLS patients incubated
with [3H]OG showed a selective deficiency (38 þ 7% of normal) in the incorporation of radioactivity into fatty acid, but no
decrease in incorporation of radioactivity into fatty alcohol, total lipids and phosphatidylethanolamine (PE). Consistent with
fatty aldehyde accumulation, incorporation of radioactivity into N-alkyl-phosphatidylethanolamine, which is derived from
Schiff base formation of free aldehyde with PE, was 4-fold higher in SLS fibroblasts compared to normal controls. Similar
results were seen with SLS keratinocytes, whereas FALDH-deficient CHO cells showed a more profound reduction in
radioactive fatty acid to 12 þ 2% of normal. These results implicate FALDH in the oxidation of ether-derived fatty aldehyde
in human and rodent cells. Metabolism of ether glycerolipids is a previously unrecognized source of fatty aldehyde that may
contribute to the pathogenesis of SLS. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Ether glycerolipids are present in most mammalian
tissues, including brain, kidney, heart, skeletal muscle
and skin [1,2]. An ether-linked saturated alkyl chain
is often present in position sn-1 of the glycerol back-
bone, but most ether glycerolipids, commonly known
as plasmalogens, contain a monounsaturated vinyl
alk-1-enyl chain. Ether glycerolipids comprise a sub-
group of the phospholipids, especially phosphatidyl-
choline and phosphatidylethanolamine (PE), and
represent a relatively high proportion of the total
lipids in certain tissues such as heart [2], brain and
myelin [3,4]. Neutral ether lipids containing acyl
groups at positions sn-2 or sn-3 are usually less com-
mon, but one such lipid (alkyldiacylglycerol) is a
prominent surface lipid on the skin [5].
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The metabolism of ether glycerolipids requires sev-
eral unique enzymes for synthesizing and cleaving the
ether bond. Formation of the ether bond is catalyzed
by alkyl-dihydroxyacetone phosphate synthase [6],
which replaces the acyl group of 1-acyl-dihydroxy-
acetone-phosphate with an ether-linked alkyl chain.
The catabolism of ether glycerolipids is catalyzed
by at least two distinct enzymes that act preferen-
tially on di¡erent ether lipid substrates. Alkyl mono-
oxygenase catalyzes the cleavage of the ether-linked
chain of alkylglycerol releasing fatty aldehyde [7^9],
whereas lysoplasmalogenase carries out the same re-
action on lysoplasmalogens (1-O-alk-1P-enyl-sn-glyc-
ero-3-phosphoethanolamine or -choline) [10^12]. Pre-
vious studies have shown that the fatty aldehyde
product of ether lipid catabolism is oxidized to fatty
acid via an NAD-dependent reaction, but the iden-
tity of the enzyme(s) catalyzing this reaction is not
known [7,8]. Likely candidate enzymes include the
aldehyde dehydrogenases, several of which have the
ability to oxidize aliphatic substrates.
Fatty aldehyde dehydrogenase (FALDH) (EC
1.2.1.48) is a microsomal NAD-dependent enzyme
that acts on long-chain aliphatic substrates [13,14].
Patients with the inherited disease Sjo«gren^Larsson
syndrome (SLS) have a genetic de¢ciency of FALDH
[15,16] and exhibit cutaneous and neurologic symp-
toms of ichthyosis, mental retardation and spasticity
[17,18]. SLS patients are de¢cient in the oxidation of
fatty aldehyde derived from fatty alcohol metabolism
[15,19], the K-oxidation of branched-chain phytanic
acid [20] and g-oxidation of leukotriene B4 [21].
These ¢ndings indicate that FALDH has a central
role in the oxidation of fatty aldehydes derived
from several diverse physiologic pathways. To deter-
mine whether FALDH is responsible for the oxida-
tion of fatty aldehyde generated from ether lipid ca-
tabolism, we investigated alkylglycerol metabolism in
cultured skin ¢broblasts and keratinocytes from SLS
patients and in a Chinese hamster ovary (CHO) cell
line that is genetically de¢cient in FALDH [22].
2. Materials and methods
2.1. Materials
All solvents were analytical grade or HPLC-grade
from Mallinckrodt and Aldrich Chemical Co. So-
dium bis(2-methoxyethoxy) aluminum hydride (Vit-
ride reagent, Red Al) was obtained from Aldrich
Chemical Co. Fatty aldehydes were synthesized
from their corresponding fatty alcohols [23]. Dimeth-
yl acetal derivatives of hexadecanal and octadecanal
were produced by transmethylation of the free alde-
hydes with methanolic-HCl. N-Alkyl-phosphatidyl-
ethanolamine (N-alkyl-PE) was synthesized accord-
ing to James and Zoeller [22]. Batyl alcohol (1-O-
octadecyl glycerol) and other lipid standards were
obtained from Sigma Chemical Co. Channeled silica
gel plates were obtained from Whatman, and silica
gel 60 high-performance (HPTLC) plates were man-
ufactured by Merck. Platelet activating factor (1-O-
[9,10-3H-octadecyl]-2-acetyl-glycero-3-phosphocho-
line) (160 Ci/mmol) and En3Hance were products of
New England Nuclear. All other chemicals were
from Sigma.
2.2. Cells
Cultured skin ¢broblasts from eight normal con-
trols and seven SLS patients were grown in Dulbec-
co’s minimal essential medium containing 10% fetal
bovine serum, penicillin and streptomycin at 37‡C in
an atmosphere of 5% CO2. Wild-type (K1) and
FALDH-de¢cient (K1A) CHO cells [22] were kindly
provided by Dr A. Zoeller, Boston University School
of Medicine. The CHO cells were grown in F12 me-
dium containing 5% fetal bovine serum, penicillin
and streptomycin. Cultured human keratinocytes
from two normal controls and two SLS patients
were grown on lethally irradiated 3T3 feeder cells
according to Randolph and Simon [24].
2.3. Radioactive alkylglycerol synthesis
1-O-[9,10-3H-Octadecyl]-glycerol ([3H]OG) was
synthesized by treating radioactive platelet activating
factor with Vitride reagent according to Snyder et al.
[25] with minor modi¢cations. Brie£y, 100 Wl of Vit-
ride reagent was added to 125 WCi platelet activating
factor in 2.5 ml of diethyl ether/benzene (80:20) and
incubated with shaking at 37‡C for 30 min. To stop
the reaction, the reaction tube was placed in an ice
bath and 200 Wl of 4% acetic acid was slowly added
dropwise followed by 1.8 ml of water. The [3H]OG
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was extracted twice into 2 ml diethyl ether, dried
under a stream of nitrogen and puri¢ed by TLC on
channeled silica gel plates using a solvent system
consisting of chloroform/methanol/water (75:30:3).
Batyl alcohol (Rf = 0.90) was co-chromatographed
as a standard, and localized by spraying the plate
with rhodamine G and observing under UV light.
The adjacent lane containing [3H]OG was not
sprayed with rhodamine. The silica region containing
[3H]OG was collected by scraping, and the [3H]OG
was eluted with chloroform/methanol (1:1), dried
under nitrogen and stored in ethanol at 4‡C.
2.4. Ether lipid content of ¢broblasts
The content of ether lipids in ¢broblasts was de-
termined by treating a cellular lipid extract with
methanolic-HCl and measuring the dimethyl acetal
content (16:0 and 18:0) by gas chromatography [26].
2.5. Enzyme assays
FALDH activity in cells was assayed using octa-
decanal as substrate [14].
2.6. Alkylglycerol metabolism in intact cells
Cells were grown to con£uency in 6-well dishes.
The growth medium was removed from each well
and replaced with 2 ml fresh medium containing
0.4^1.2 nM [3H]OG (200 000^600 000 cpm), which
was previously added to the culture medium as an
ethanolic solution and then incubated with shaking
at 37‡C for 30 min. Cells were incubated at 37‡C for
varying periods of time. The radioactive media were
removed and cell monolayers washed with phos-
phate-bu¡ered saline (PBS). Cells were collected by
trypsinization (¢broblasts and CHO cells) or scrap-
ing (keratinocytes). The cell pellets were washed once
with PBS and pelleted by centrifugation at 3000Ug.
Fibroblasts and CHO cell pellets were dispersed by
vortexing and extracted with 2.5 ml chloroform/
methanol (1:1), whereas the keratinocyte pellets
were homogenized using a motor-driven Tissue Tea-
ror (Biospec Products) prior to extraction. After re-
moval of precipitated proteins by centrifugation and
transfer of the organic solvent to new glass tubes,
lipid extracts were washed according to Folch et al.
[27] by adding 1.25 ml of chloroform and 0.75 ml
water, vortexing and discarding the upper phase. The
lower organic phase was washed once with 2 ml of
theoretical upper phase consisting of chloroform/
methanol/water (15:240:235) and subsequently dried
under a stream of nitrogen. To determine the radio-
active fatty acid and fatty alcohol, the lipid extracts
were resuspended in 1.5 ml of 0.3 N NaOH in 95%
ethanol and heated at 90‡C for 2 h. After addition of
2 ml water, non-saponi¢able lipids were extracted
with 4 ml hexane, dried under nitrogen and fatty
alcohols were puri¢ed by TLC using a solvent system
consisting of hexane/chloroform/methanol (73:25:2).
To collect radioactive fatty acids, the remaining lip-
ids in NaOH/ethanol were acidi¢ed by addition of
1 ml of 2 N HCl and saponi¢able lipids were ex-
tracted into hexane. Fatty acids were puri¢ed by
TLC using a solvent system consisting of hexane/
ether/acetic acid (60:40:1). Lipid standards were co-
chromatographed and the regions containing fatty
alcohol and fatty acid were visualized under UV light
after spraying the plates with rhodamine G. Radio-
active lipid regions were collected by scraping and
counted. The protein content of the cells was deter-
mined [28] and radioactive lipid data were expressed
as cpm/mg protein or cpm/h per mg protein.
To screen ¢broblasts for incorporation of [3H]OG
into cell lipids, cells were incubated with [3H]OG for
24 h, collected by trypsinization, and cell lipids were
extracted and washed according to Folch et al. [27]
as described above. Lipids were separated on
HPTLC plates using a two-step solvent system con-
sisting of chloroform/methanol/acetic acid/formic
acid/water (35:15:6:2:1) to 3 cm, followed by hex-
ane/ether/acetic acid (32:17:1) to the top of the plate.
Appropriate lipid standards were co-chromato-
graphed in separate lanes and visualized under UV
light after spraying the plate with rhodamine G. The
region of the plate containing radioactive lipids was
sprayed with En3Hance and lipids were detected by
£uorography.
2.7. Incorporation of radioactivity into N-alkyl-
phosphatidylethanolamine (N-alkyl-PE)
To measure radioactive N-alkyl-PE, cells were in-
cubated with culture medium containing 1.2 nM
[3H]OG for 24 h as described above. The culture
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medium was replaced with PBS containing 25 mM
NaBH3CN and cells were incubated at 37‡ for 2 h
[22]. Cells from six wells were collected by scraping,
pooled, washed with PBS and extracted with chloro-
form/methanol (1:1) as described above. The lipid
extract was washed according to Folch et al. [27]
and dried under a stream of nitrogen. Lipids were
redissolved in 0.2 ml chloroform/methanol (1:1) and
applied to a 1ml disposable silica gel column (Baker
spe) previously equilibrated with chloroform. The
column was washed with 5 ml chloroform/methanol
(90:10) and phospholipids (including N-alkyl-PE)
eluted with chloroform/methanol (1:1). The lipid el-
uate containing N-alkyl-PE was dried and treated
with 1.5 ml of 1 N methanolic-HCl for 2 h at
90‡C. After cooling, the N-alkylethanolamine hydro-
lysis product of N-alkyl-PE together with other prod-
ucts were dried under a stream of nitrogen, dissolved
in 0.2 ml chloroform/methanol (1:1) and applied to a
disposable silica column previously equilibrated with
chloroform. The column was washed with 5 ml hex-
ane/ether (90:10), and N-alkylethanolamine was
eluted with chloroform/methanol (1:1), dried and pu-
ri¢ed by chromatography on a silica gel plate using a
solvent system consisting of chloroform/methanol/
acetic acid (80:20:2). Authentic N-alkylethanolamine
was co-chromatographed as a standard. The plate
was sprayed with rhodamine, visualized under UV
light, and the region corresponding to N-alkyletha-
nolamine was collected and counted. The amount of
N-alkylethanolamine derived from cell N-alkyl-PE
was not corrected for recovery, which was 71 þ 6%
(n = 4) based on using N-[1-14C]octadecyl-PE in the
procedure.
3. Results
3.1. Biochemical characteristics of SLS ¢broblasts,
keratinocytes and CHO cells
The activity of FALDH in SLS ¢broblasts and
keratinocytes was only 8 þ 4% and 6 þ 2% of normal
controls, respectively. The FALDH activity of mu-
tant CHO K1A cells was 8 þ 2% of that measured in
the wild-type K1 cells. The ether lipid content of the
SLS ¢broblasts (6.30 þ 1.21 Wg/mg protein) was no
di¡erent from normal controls (6.37 þ 0.72 Wg/mg
protein), based on measuring dimethyl acetal alde-
hyde derivatives in total lipids.
3.2. Alkylglycerol metabolism in intact ¢broblasts
We investigated the ability of normal intact ¢bro-
blasts to catabolize 1-O-[9,10-3H-octadecyl]-glycerol
([3H]OG) and incorporate its radioactive fatty alde-
hyde product into fatty acid. As shown in Fig. 1A,
normal cells incubated with [3H]OG showed a linear
time-dependent accumulation of radioactive fatty
acid for at least 24 h. With increasing amounts of
Fig. 1. Incorporation of radioactivity from [3H]OG into fatty
acids by normal human ¢broblasts. (A) Time course. Each cul-
ture well contained 0.088 mg cell protein and 1.2 nM [3H]OG
(6U105 cpm) in 2 ml of culture medium. (B) [3H]OG concen-
tration dependence. Incubations were for 5 h with 0.094 mg cell
protein/well.
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[3H]OG, the ¢broblasts showed a concentration de-
pendent increase in radioactive fatty acid (Fig. 1B).
When cells were incubated with 1.2 nM [3H]OG for
24 h, only 1.39 þ 0.09% of the cell-associated radio-
activity was recovered as fatty acid. Radioactivity
from alkylglycerol was also incorporated into fatty
alcohol by the cells, probably via reduction of radio-
active fatty aldehyde, at a level of 27 þ 8% of that
seen in cellular fatty acid. After TLC of the cell lipid
extracts, about one-third of the radioactive substrate
remained unmetabolized, but the majority of [3H]OG
was found to be used for synthesis of cellular PE and
an unidenti¢ed neutral lipid that migrated close to
the triglyceride region (Fig. 2). This neutral lipid did
not co-migrate with alkyldiacylglycerol, which runs
slightly ahead of triglyceride on TLC.
To determine whether FALDH is necessary for
oxidation of the fatty aldehyde released during ether
lipid catabolism, we compared the metabolism of
[3H]OG in ¢broblasts from normal subjects with cells
from SLS patients. When cell cultures were incu-
bated with 1.2 nM [3H]OG, SLS and normal cells
took up a comparable amount of radioactive lipid,
but the SLS ¢broblasts had an impaired ability
(38 þ 7% of normal) to accumulate radioactive fatty
acid (Fig. 3). In striking contrast to fatty acids, the
incorporation of radioactivity from [3H]OG into cel-
lular fatty alcohol was not decreased in SLS, indicat-
ing that the ¢rst step in ether lipid catabolism that
generates fatty aldehyde occurred normally. As
shown in Fig. 2, both normal and SLS ¢broblasts
showed an equal ability to incorporate [3H]OG into
cellular PE and the unidenti¢ed neutral lipid, indicat-
ing that biosynthetic pathways for alkylglycerol were
not abnormal in SLS.
3.3. Alkylglycerol metabolism in FALDH-de¢cient
keratinocytes and Chinese hamster ovary cells
To test whether the results with SLS ¢broblasts
were speci¢c for this type of cell, we compared
[3H]OG metabolism in cultured keratinocytes from
SLS patients and normal controls. Similar studies
were also performed with mutant Chinese hamster
ovary (K1A) cells lacking FALDH activity compared
to wild-type cells (K1). Surprisingly, the human ker-
Fig. 3. Uptake and incorporation of radioactivity from [3H]OG
into total lipids, fatty acid and fatty alcohol by normal and
SLS ¢broblasts. Cells were incubated with 1.2 nM [3H]OG for
24 h. Results shown are composite data from four separate ex-
periments with eight di¡erent normal cell lines and seven SLS
cell lines. Incorporation data were normalized to cell protein
and expressed as a percentage ( þ S.D.) of the mean radioactiv-
ity seen in normal control ¢broblasts. The following radioactiv-
ities was measured in normal ¢broblasts: total lipids,
4 083 592 þ 96 532 cpm/mg protein; fatty acid, 57 042 þ 3870
cpm/mg protein; fatty alcohol, 15 601 cpm/mg protein. Filled
bars, normal controls; open bars, SLS. *Data are statistically
di¡erent from normal at P6 0.0001 using t-test.
Fig. 2. Metabolism of [3H]OG in normal and SLS ¢broblasts.
Cells were incubated with 1.2 nM [3H]OG (6U105 cpm) for 24
h. Cell lipids were separated by TLC and visualized by £uorog-
raphy. TG, triglyceride; Chol, cholesterol ; OG, 1-O-octadecyl
glycerol ; PE, phosphatidylethanolamine; PC, phosphatidylcho-
line; Sm, sphingomyelin, X, unidenti¢ed lipid.
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atinocytes possessed a very low incorporation of ra-
dioactivity into fatty acid compared to hamster cells
(Table 1). In both cell types, however, the FALDH-
de¢cient cells showed a reduction in the incorpora-
tion of radioactivity derived from [3H]OG into fatty
acid, whereas incorporation of radioactivity into
fatty alcohol tended to be increased (Table 1). The
relative de¢ciency in incorporation of radioactivity
into fatty acids in SLS keratinocytes (40 þ 5% of nor-
mal) was similar to that seen in the SLS ¢broblasts.
In contrast, the mutant K1A cells showed a more
profound reduction in metabolism of [3H]OG to
fatty acid (12 þ 2% of the mean radioactivity seen
in the K1 cells).
3.4. Incorporation of radioactivity from [3H]OG into
N-alkyl-PE
Fatty aldehyde accumulation in SLS has been
shown to result in formation of an aldehyde-depen-
dent Schi¡ base derivative with PE, which can be
reduced to generate N-alkyl-PE [22]. To determine
whether the block in [3H]OG metabolism in
FALDH-de¢cient cells led to diversion of radioactive
fatty aldehyde into N-alkyl-PE, we incubated ¢bro-
blasts with [3H]OG for 24 h. After extraction and
puri¢cation of cellular phospholipids, the N-alkyl-
PE was treated with acid to release N-alkyl-ethanol-
amine, which was then isolated (see Section 2). The
amount of radioactive N-alkyl-ethanolamine in SLS
¢broblasts (1851 þ 707 cpm/mg protein, n = 4) was
increased 4-fold (P = 0.003) compared to normal cells
(411 þ 213 cpm/mg protein, n = 5).
4. Discussion
To determine whether microsomal FALDH was
necessary for the oxidation of fatty aldehyde derived
from ether lipid catabolism, we investigated [3H]OG
metabolism in human ¢broblasts, human keratino-
cytes and Chinese hamster ovary cells that were ge-
netically de¢cient in this enzyme. Our results indicate
that FALDH is responsible in large part for catalyz-
ing this reaction. The selective de¢ciency in incorpo-
ration of radioactivity from [3H]OG into fatty acids
compared to fatty alcohols by SLS ¢broblasts and
the accumulation of radioactive N-alkyl-PE are con-
sistent with normal alkylglycerol cleavage but a de-
fect in aldehyde oxidation. Other measures of alkyl-
glycerol metabolism appeared normal in SLS
¢broblasts, including the total ether lipid content as
determined by dimethyl acetal level, cellular uptake
of [3H]OG and its incorporation into phospholipids.
This latter ¢nding, together with the observation that
SLS cells showed no reduction in radioactive fatty
alcohol or N-alkyl-PE, suggests that the intracellular
alkylglycerol pools were not altered in SLS cells.
Thus, the defect in alkylglycerol metabolism in SLS
¢broblasts was limited to oxidation of ether-derived
aldehyde. Similar results in keratinocytes from SLS
patients and genetically mutant CHO K1A cells in-
dicate that FALDH acts to oxidize alkylglycerol-de-
rived fatty aldehyde in other skin cells and species.
The FALDH-de¢cient CHO cells showed a more
profound reduction (12 þ 2% of normal) than the
human SLS cells (38^40% of normal) in incorporat-
ing radioactivity from [3H]OG into fatty acid. The
Table 1
Incorporation of radioactivity derived from [3H]OG into cellular fatty acid and fatty alcohol by con£uent human keratinocytes and
Chinese hamster ovary (CHO) cellsa
Cells [3H]Fatty acid (cpm/h per mg protein) [3H]Fatty alcohol (cpm/h per mg protein)
Human keratinocytes
Normal controls (n = 3) 15.2 þ 3.7 14.6 þ 4.3
SLS (n = 4) 6.1 þ 0.7b 21.7 þ 0.4c
Chinese hamster ovary cells
K1 (wild-type) (n = 4) 4689 þ 698 252 þ 60
K1A (FALDH-de¢cient) (n = 4) 573 þ 110d 369 þ 39c
aCells were incubated with 1.2 nM [3H]OG for 24 h. Data are expressed as mean þ S.D.
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residual activity in SLS cells is beyond that expected
from the FALDH enzymatic defect (6 10% of nor-
mal) and suggests the existence of another enzyme or
alternate pathway for aldehyde oxidation in humans.
The nature of this alternate pathway is not known
and it is unclear whether it accounts for a similar
degree of fatty aldehyde oxidation under normal
conditions when FALDH is active. FALDH has a
widespread tissue expression in humans [29,30] and
rodents [31], but shows signi¢cant variation between
tissues. At least 12 aldehyde dehydrogenases have
been identi¢ed in humans and some of these enzymes
are capable of oxidizing aliphatic substrates [32,33].
One potential candidate for the residual aldehyde
oxidative activity is ALDH3, a cytosolic enzyme
that has activity against aliphatic aldehydes [34].
The genes for ALDH3 and FALDH are found at
the same locus on chromosome 17p11.2 [16,29,34]
and appear to be closely related. However, ALDH3
does not contribute to this pathway, because the re-
sidual oxidative activity was not further reduced in
¢broblasts from an unusual SLS patient with a large
genetic deletion that eliminates both FALDH and
ALDH3 (unpublished observations).
Incorporation of radioactivity from [3H]OG into
fatty acid by normal human keratinocytes was
much lower than that seen in human ¢broblasts
or CHO cells. This striking di¡erence may re£ect
a lower alkylglycerol-cleavage activity in the kerati-
nocytes, or a greater endogenous alkylglycerol pool
that would tend to dilute the speci¢c activity of the
intracellular [3H]OG and lower the incorporation
of radioactivity into other lipids. Alkylglycerol
cleavage activity tends to be low in tissues that
have high ether lipid levels [2] and rat keratinocytes
synthesize considerable amounts of neutral ether lip-
ids [35].
The symptoms of SLS are thought to originate
from the accumulation of certain lipids due to de¢-
cient FALDH activity [36]. These lipids include ali-
phatic alcohols, such as octadecanol [37,38] and g-
hydroxy-leukotriene B4 [21], which require FALDH
for their complete oxidation to the corresponding
acids. Free fatty aldehydes are direct substrates for
FALDH, but they are not readily detected in tissues
or cultured cells from SLS patients, perhaps in part
because aldehydes are chemically reactive groups
that readily form covalent adducts with other mole-
cules. Indirect evidence for fatty aldehyde accumula-
tion in SLS is the increased formation of N-alkyl-PE,
which is the reduction product of an aldehyde-depen-
dent Schi¡ base with PE [22]. Although the patho-
genic mechanisms are unclear, fatty aldehydes have
been shown to be toxic to cultured CHO cells, and
FALDH-de¢cient cells are particularly susceptible to
these lipids compared to wild-type cells [22].
Our results identify ether glycerolipids as a source
of fatty aldehyde that accumulates in SLS. The rela-
tive contribution of ether lipids to the fatty aldehyde
pool in SLS probably varies among tissues depend-
ing on their ether lipid levels and catabolic rates.
Alkyldiacylglycerol accounts for up to 15% of the
total lipids in cultured rat keratinocytes [35] and on
the surface of the skin [5]. Plasmalogens are partic-
ularly abundant lipids in myelin membranes, com-
prising 40^50% of the total PE [4], and plasmalogen
PE in myelin is metabolically active with a half-life of
several days [39]. Since ichthyosis is a major feature
of SLS [17,18] and myelin abnormalities are com-
monly seen [40], it is tempting to speculate that the
metabolic turnover of ether glycerolipids in the skin
and myelin of SLS patients generates considerable
amounts of fatty aldehyde that may be responsible
in part for the pathogenesis of this disease.
Acknowledgements
This research was supported by grant AR44552
from the National Institutes of Health.
References
[1] F. Snyder, Ether Lipids. Chemistry and Biology, Academic
Press, New York, 1972.
[2] L.A. Horrocks, M. Sharma, Plasmalogens and O-alkyl glyc-
erophospholipids, in: J.N. Hawthorne, G.B. Ansell (Eds.),
Phospholipids, Elsevier Biomedical, New York, 1982, pp.
51^93.
[3] A.L. Ganser, A.-L. Kerner, B. Brown, M.T. Davisson, D.A.
Kirschner, A survey of neurological mutant mice. I. Lipid
composition of myelinated tissue in known myelin mutants,
Dev. Neurosci. 10 (1988) 99^122.
[4] J.S. O’Brien, E.L. Sampson, Lipid composition of the nor-
mal human brain: gray matter, white matter, and myelin,
J. Lipid Res. 6 (1965) 537^544.
[5] H. Oku, J. Shudo, K. Mimura, A. Haratake, J. Nagata, I.
BBADIS 61991 24-11-00
W.B. Rizzo et al. / Biochimica et Biophysica Acta 1535 (2000) 1^9 7
Chinen, 1-O-Alkyl-2,3-diacylglycerols in the skin surface lip-
ids of the hairless mouse, Lipids 30 (1995) 169^172.
[6] H. van den Bosch, E.C.J.M. de Vet, Alkyl-dihydroxyaceto-
nephosphate synthase, Biochim. Biophys. Acta 1348 (1997)
35^44.
[7] A. Tietz, M. Lindberg, E.P. Kennedy, A new pteridine-re-
quiring enzyme system for the oxidation of glyceryl ethers,
J. Biol. Chem. 239 (1964) 4081^4090.
[8] J.F. Soodsma, C. Piantadosi, F. Snyder, Partial character-
ization of the alkylglycerol cleavage enzyme system of rat
liver, J. Biol. Chem. 247 (1972) 3923^3929.
[9] J. Ko«tting, C. Unger, H. Eibl, Substrate speci¢city of O-
alkylglycerol monooxygenase (E.C. 1.14.16.5), solubilized
from rat liver microsomes, Lipids 22 (1987) 831^835.
[10] J. Gunawan, H. Debuch, Lysoplasmalogenase ^ a microso-
mal enzyme from rat brain, J. Neurochem. 39 (1982) 693^
699.
[11] M. Jurkowitz-Alexander, H. Ebata, J.S. Mills, E.J. Murphy,
L.A. Horrocks, Solubilization, puri¢cation and characteriza-
tion of lysoplasmalogen alkenylhydrolase (lysoplasmaloge-
nase) from rat liver microsomes, Biochim. Biophys. Acta
1002 (1989) 203^212.
[12] M.S. Jurkowitz, L.A. Horrocks, M.L. Litsky, Identi¢cation
and characterization of alkenyl hydrolase (lysoplasmaloge-
nase) in microsomes and identi¢cation of a plasmalogen-ac-
tive phospholipase A2 in cytosol of small intestine epitheli-
um, Biochim. Biophys. Acta 1437 (1999) 142^156.
[13] H. Nakayasu, K. Mihara, R. Sato, Puri¢cation and proper-
ties of a membrane-bound aldehyde dehydrogenase from rat
liver microsomes, Biochem. Biophys. Res. Commun. 83
(1978) 697^703.
[14] T.L. Kelson, J.R. Secor McVoy, W.B. Rizzo, Human liver
fatty aldehyde dehydrogenase: microsomal localization, pu-
ri¢cation, and biochemical characterization, Biochim. Bio-
phys. Acta 1335 (1997) 99^110.
[15] W.B. Rizzo, D.A. Craft, Sjo«gren^Larsson syndrome. De¢-
cient activity of the fatty aldehyde dehydrogenase compo-
nent of fatty alcohol:NAD oxidoreductase in cultured ¢bro-
blasts, J. Clin. Invest. 88 (1991) 1643^1648.
[16] V. De Laurenzi, G.R. Rogers, D.J. Hamrock, L.N. Mare-
kov, P.M. Steinert, J.G. Compton, N. Markova, W.B. Riz-
zo, Sjo«gren^Larsson syndrome is caused by mutations in the
fatty aldehyde dehydrogenase gene, Nat. Genet. 12 (1996)
52^57.
[17] T. Sjo«gren, T. Larsson, Oligophrenia in combination with
congenital ichthyosis and spastic disorders, Acta Psychiatr.
Neurol. Scand. 32 (Suppl. 113) (1957) 1^113.
[18] W.B. Rizzo, Sjo«gren^Larsson syndrome, Semin. Dermatol.
12 (1993) 210^218.
[19] W.B. Rizzo, A.L. Dammann, D.A. Craft, Sjo«gren^Larsson
syndrome: impaired fatty alcohol oxidation in cultured ¢-
broblasts due to de¢cient fatty alcohol:nicotinamide adenine
dinucleotide oxidoreductase activity, J. Clin. Invest. 81
(1988) 738^744.
[20] N.M. Verhoeven, C. Jakobs, G. Carney, M.P. Somers,
R.J.A. Wanders, W.B. Rizzo, Involvement of microsomal
fatty aldehyde dehydrogenase in the K-oxidation of phytanic
acid, FEBS Lett. 429 (1998) 225^228.
[21] M.A.A.P. Willemsen, J.G.N. de Jong, P.H.M.F. van Dom-
burg, J.J. Rotteveel, R.J.A. Wanders, E. Mayatepek, Defec-
tive inactivation of leukotriene B4 in patients with Sjo«gren^
Larsson syndrome, J. Pediatr. 136 (2000) 258^260.
[22] P.F. James, R.A. Zoeller, Isolation of animal cell mutants
defective in long-chain fatty aldehyde dehydrogenase. Sensi-
tivity to fatty aldehydes and Schi¡’s base modi¢cation of
phospholipids: implications for Sjo«gren^Larsson syndrome,
J. Biol. Chem. 272 (1997) 23532^23539.
[23] A.J. Valicenti, R.T. Holman, Oxidation of long-chain alco-
hols to aldehydes by the dipyridine chromic anhydride com-
plex, Chem. Phys. Lipids 17 (1976) 389^392.
[24] R.K. Randolph, M. Simon, Characterization of retinol me-
tabolism in cultured human epidermal keratinocytes, J. Biol.
Chem. 268 (1993) 9198^9205.
[25] F. Snyder, M. Blank, R.L. Wykle, The enzymic synthesis of
ethanolamine plasmalogens, J. Biol. Chem. 246 (1971) 3639^
3645.
[26] I. Bjo«rkhem, L. Sisfontes, B. Bostro«m, B.F. Kase, R. Blom-
strand, Simple diagnosis of the Zellweger syndrome by gas^
liquid chromatography of dimethylacetals, J. Lipid Res. 27
(1986) 786^791.
[27] J. Folch, M. Lees, G.H.S. Sloane Stanley, A simple method
for isolation and puri¢cation of total lipids from animal
tissues, J. Biol. Chem. 226 (1957) 497^509.
[28] O.H. Lowry, J.J. Rosebrough, A.L. Farr, R.J. Randall, Pro-
tein measurement with the Folin phenol reagent, J. Biol.
Chem. 193 (1951) 265^275.
[29] G.R. Rogers, N.G. Markova, V. De Laurenzi, W.B. Rizzo,
J.G. Compton, Genomic organization and expression of the
human fatty aldehyde dehydrogenase gene (FALDH), Ge-
nomics 39 (1997) 127^135.
[30] C. Chang, A. Yoshida, Human fatty aldehyde dehydroge-
nase gene (ALDH10): organization and tissue-dependent ex-
pression, Genomics 40 (1997) 80^85.
[31] K. Miyauchi, R. Masaki, S. Taketani, A. Yamamoto, M.
Akayama, Y. Tashiro, Molecular cloning, sequencing, and
expression of cDNA for rat liver microsomal aldehyde de-
hydrogenase, J. Biol. Chem. 266 (1991) 19536^19542.
[32] A. Yoshida, A. Rzhetsky, L.C. Hsu, C. Chang, Human al-
dehyde dehydrogenase gene family, Eur. J. Biochem. 251
(1998) 549^557.
[33] J. Perozich, H. Nicholas, B.C. Wang, R. Lindahl, J. Hempel,
Relationships within the aldehyde dehydrogenase extended
family, Protein Sci. 8 (1999) 137^146.
[34] I. Santisteban, S. Povey, L.F. West, J.M. Parrington, D.A.
Hopkinson, Chromosome assignment, biochemical and im-
munological studies on a human aldehyde dehydrogenase,
ALDH3, Ann. Hum. Genet. 49 (1985) 87^100.
[35] H. Oku, J. Shudo, J. Nagata, I. Chinen, Accumulation of
1-O-alkyl-2,3-diacylglycerols in cultured rat keratinocytes,
Biochim. Biophys. Acta 1300 (1996) 35^41.
[36] W.B. Rizzo, New clues to the pathogenesis of Sjo«gren^Lars-
son syndrome, J. Mol. Neurosci. 13 (1999) 227^228.
BBADIS 61991 24-11-00
W.B. Rizzo et al. / Biochimica et Biophysica Acta 1535 (2000) 1^98
[37] W.B. Rizzo, A.L. Dammann, D.A. Craft, S.H. Black, A.
Henderson Tilton, D. Africk, E. Chaves-Carballo, G.
Holmgren, S. Jagell, Sjo«gren^Larsson syndrome: inherited
defect in the fatty alcohol cycle, J. Pediatr. 115 (1989) 228^
234.
[38] W.B. Rizzo, D.A. Craft, Sjo«gren^Larsson syndrome: accu-
mulation of free fatty alcohols in cultured ¢broblasts and
plasma, J. Lipid Res. 41 (2000) 1077^1081.
[39] L.A. Horrocks, Metabolism of the ethanolamine phospho-
glycerides of mouse brain myelin and microsomes, J. Neuro-
chem. 16 (1969) 13^18.
[40] P.H.M.F. van Domburg, M.A.A.P. Willemsen, J.J. Rotte-
veel, J.G.N. de Jong, H.O.M. Thijssen, A. Heerschap,
J.R.M. Cruysberg, R.J.A. Wanders, F.J.M. Gabree«ls, P.M.
Steijlen, Sjo«gren^Larsson syndrome. Clinical and MRI/MRS
¢ndings in FALDH de¢cient patients, Neurology 52 (1999)
1345^1352.
BBADIS 61991 24-11-00
W.B. Rizzo et al. / Biochimica et Biophysica Acta 1535 (2000) 1^9 9
